{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025155","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.948447+00:00","generated_at":"2026-05-16T16:26:40.260954+00:00","sec_items":["1.01","1.02"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nephros signs exclusive license & supply deal with Medica; min purchases €4.98M-€6.3M/yr through 2030","bullets":["Replaces prior Dec 2023 License & Supply Agreement with Medica; that agreement terminated.","Nephros receives exclusive right to market & sell Products using Medica's Medisulfone ultrafiltration tech.","Minimum annual purchases from Medica: €4.976M (2026), €5.349M (2027), €5.750M (2028), €6.000M (2029), €6.300M (2030).","Term through Dec 31, 2030; Nephros may terminate for convenience with 90 days' notice; Medica may terminate for uncured monetary default."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025155","json":"https://secwatch.observer/filing/0001493152-25-025155.json","markdown":"https://secwatch.observer/filing/0001493152-25-025155.md","text":"https://secwatch.observer/filing/0001493152-25-025155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315225025155/0001493152-25-025155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315225025155/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:26:40.260954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}